271 related articles for article (PubMed ID: 36355455)
1. Improving outcomes in scleroderma: recent progress of cell-based therapies.
Khanna D; Krieger N; Sullivan KM
Rheumatology (Oxford); 2023 Jun; 62(6):2060-2069. PubMed ID: 36355455
[TBL] [Abstract][Full Text] [Related]
2. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of mesenchymal stromal cell transplantation in systemic scleroderma].
Lansiaux P; Farge D
Rev Prat; 2022 Apr; 72(4):355-362. PubMed ID: 35638974
[TBL] [Abstract][Full Text] [Related]
4. [Systemic sclerosis--clinical course and treatment possibilities].
Szymańska E; Maj M; Rudnicka L
Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
[TBL] [Abstract][Full Text] [Related]
5. Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis.
Adamska JZ; Zia A; Bloom MS; Crofford LJ; Furst DE; Goldmuntz E; Keyes-Elstein L; Mayes MD; McSweeney P; Nash RA; Pinckney A; Welch B; Love ZZ; Sullivan KM; Robinson W
Ann Rheum Dis; 2023 Mar; 82(3):357-364. PubMed ID: 36241361
[TBL] [Abstract][Full Text] [Related]
6. Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
Zhao M; Wu J; Wu H; Sawalha AH; Lu Q
Clin Rev Allergy Immunol; 2022 Apr; 62(2):273-291. PubMed ID: 33449302
[TBL] [Abstract][Full Text] [Related]
7. Fat Grafting for the Treatment of Scleroderma.
Strong AL; Rubin JP; Kozlow JH; Cederna PS
Plast Reconstr Surg; 2019 Dec; 144(6):1498-1507. PubMed ID: 31764674
[TBL] [Abstract][Full Text] [Related]
8. Cellular Therapies in Systemic Sclerosis: Recent Progress.
van Rhijn-Brouwer FC; Gremmels H; Fledderus JO; Radstake TR; Verhaar MC; van Laar JM
Curr Rheumatol Rep; 2016 Feb; 18(2):12. PubMed ID: 26943351
[TBL] [Abstract][Full Text] [Related]
9. The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation.
Servaas NH; Spierings J; Pandit A; van Laar JM
Clin Exp Immunol; 2020 Jul; 201(1):34-39. PubMed ID: 31990046
[TBL] [Abstract][Full Text] [Related]
10. [Juvenile scleroderma].
de Mâcedo PA; Shinjo SK; Goldenstein-Schainberg C
Acta Reumatol Port; 2008; 33(3):289-97. PubMed ID: 18846006
[TBL] [Abstract][Full Text] [Related]
11. Localized scleroderma: clinical spectrum and therapeutic update.
Careta MF; Romiti R
An Bras Dermatol; 2015; 90(1):62-73. PubMed ID: 25672301
[TBL] [Abstract][Full Text] [Related]
12. Juvenile Scleroderma-What has Changed in the Meantime?
Adrovic A; Sahin S; Barut K; Kasapcopur O
Curr Rheumatol Rev; 2018; 14(3):219-225. PubMed ID: 29692255
[TBL] [Abstract][Full Text] [Related]
13. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party.
Henes J; Oliveira MC; Labopin M; Badoglio M; Scherer HU; Del Papa N; Daikeler T; Schmalzing M; Schroers R; Martin T; Pugnet G; Simoes B; Michonneau D; Marijt EWA; Lioure B; Olivier Bay J; Snowden JA; Rovira M; Huynh A; Onida F; Kanz L; Marjanovic Z; Farge D
Haematologica; 2021 Feb; 106(2):375-383. PubMed ID: 31949011
[TBL] [Abstract][Full Text] [Related]
14. Scleroderma and fasciitis in children.
Black CM
Curr Opin Rheumatol; 1995 Sep; 7(5):442-8. PubMed ID: 8519619
[TBL] [Abstract][Full Text] [Related]
15. Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches.
Xue E; Minniti A; Alexander T; Del Papa N; Greco R; On Behalf Of The Autoimmune Diseases Working Party Adwp Of The European Society For Blood And Marrow Transplantation Ebmt
Cells; 2022 Oct; 11(21):. PubMed ID: 36359742
[TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation in scleroderma.
Farge D; Ait Abdallah N; Marjanovic Z; Del Papa N
Presse Med; 2021 Apr; 50(1):104065. PubMed ID: 33548374
[TBL] [Abstract][Full Text] [Related]
17. Case report: A successful second autologous hematopoietic stem cell transplantation in refractory systemic sclerosis, with positive effect on skin involvement, pulmonary function and microcirculation.
Haverkort DA; Kersten BE; van Rhenen A; van der Velden WJFM; Vonk MC
Front Immunol; 2022; 13():925776. PubMed ID: 36505455
[TBL] [Abstract][Full Text] [Related]
18. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
19. Stem cells therapy: the future in the management of systemic sclerosis? A case report.
Song JI; Volz S; Liodaki ME; Mailänder P; Kalousis K
Hell J Nucl Med; 2017; 20 Suppl():164. PubMed ID: 29324934
[TBL] [Abstract][Full Text] [Related]
20. Update on stem cell transplantation for systemic sclerosis: recent trial results.
Naraghi K; van Laar JM
Curr Rheumatol Rep; 2013 May; 15(5):326. PubMed ID: 23516015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
